Actualités AnorTech Inc - ANOR | Actions TSX Venture Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

AnorTech Grants Stock Options

VANCOUVER, British Columbia, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ANORTECH INC. (“AnorTech” or the “Company”...

AnorTech Completes 2024 Field Program at Gronne Bjerg Anorthosite Project in Greenland

VANCOUVER, British Columbia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- ANORTECH INC. (“AnorTech” or the “Company”...

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Acquisition to Strengthen Transplant and Oncology Businesses CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme...

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR; TSX:...

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED Board Recommends Shareholders Accept Genzyme Offer LANGLEY, BC, Nov. 3 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the...

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

VANCOUVER, Oct. 23 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that it has completed enrollment in the second...

AnorMED and Genzyme reach agreement on acquisition

Genzyme to Gain Late-Stage Transplantation Product Candidate VANCOUVER, BC, and CAMBRIDGE, MA, Oct. 17 /PRNewswire-FirstCall/ -- Genzyme...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the...

AnorMED announces receipt of proposal from Genzyme Corporation

VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) announced today that it has received a proposal from Genzyme...

Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash

CAMBRIDGE, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) announced today that it has informed the Board of...

AnorMED Board recommends shareholders accept Millennium offer

VANCOUVER, Oct. 5 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (NASDAQ:ANOR; TSX:AOM) announced today that its Board of...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AnorTech Inc (ANOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ANOR Actualités

AnorTech Grants Stock Options

AnorTech Completes 2024 Field Program at Gronne Bjerg Anorthosite Project in Greenland

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

AnorMED and Genzyme reach agreement on acquisition

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED announces receipt of proposal from Genzyme Corporation

Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash

AnorMED Board recommends shareholders accept Millennium offer

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AnorTech Inc (ANOR) Actualités

AnorTech Inc (ANOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

ANOR Actualités

AnorTech Grants Stock Options

AnorTech Completes 2024 Field Program at Gronne Bjerg Anorthosite Project in Greenland

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

AnorMED and Genzyme reach agreement on acquisition

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED has determined Genzyme's offer is a 'superior proposal'

AnorMED announces receipt of proposal from Genzyme Corporation

Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash

AnorMED Board recommends shareholders accept Millennium offer

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres